US states move for final nod on Bausch, Lannett settlements in generic drug antitrust case
( May 20, 2026, 20:19 GMT | Official Statement) -- MLex Summary: US states asked a federal judge to approve their settlements with Bausch Health and Lannett Company to resolve allegations that they conspired to artificially inflate and manipulate prices for numerous generic prescription drugs. If approved, Bausch will pay $4.1 million and Lannett will pay $13.8 million.See attached file....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.